Mainz BioMed NV (MYNZ)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current MYNZ market cap is 10.04M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 250k | 249k | 181k | 215k | |
| Operating Income | -6.56M | -7.93M | -5.64M | -6.54M | |
| Net Income | -6.56M | -8.25M | -6.3M | -5.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 281k | 493k | 577k | 529k | 895k |
| Operating Income | -921k | -674k | -9.73M | -26.18M | -26.6M |
| Net Income | -957k | -587k | -11.69M | -26.39M | -26.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.54M | 19.31M | 17.91M | 15.41M | |
| Total Liabilities | 9.86M | 14.13M | 14.46M | 12.16M | |
| Total Equity | 9.68M | 5.18M | 3.45M | 3.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 0 | 673k | 10.04M | 20.24M | 15.41M |
| Total Liabilities | 0 | 3.41M | 3.68M | 6.15M | 12.16M |
| Total Equity | 0 | -2.74M | 6.36M | 14.1M | 3.25M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.66M | -10.78M | -17.28M | -21.94M | |
| Investing | -1.4M | -1.53M | -1.64M | -1.9M | |
| Financing | 773k | 6.19M | 10.76M | 14.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -416k | -468k | -3.22M | -14.77M | -21.94M |
| Investing | N/A | -9k | 1.2M | -658k | -1.9M |
| Financing | 423k | 396k | 10.61M | 23.94M | 14.23M |
| Market Cap | 10.04M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 2M |
| Average Volume (1 week) | 162.73k |
| Average Volume (1 Month) | 1.76M |
| 52 Week Change | -88.79% |
| 52 Week High | 53.60 |
| 52 Week Low | 3.65 |
| Spread (Intraday) | 0.71 (12.89%) |
| Company Name | Mainz BioMed NV |
| Address |
keizersgracht 391a amsterdam, north holland |
| Website | https://www.mainzbiomed.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
